Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis

Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis

US Patent 7811812 · Granted Oct 12, 2010

Estimated economic value: $14,423,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for activating “stimulator of interferon gene”13 depend2021
Compositions and methods for activating “stimulator of interferon gene”-dependen2021
Compositions and methods for activating “stimulator of interferon gene”-dependen2020
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and u2020
Compositions and methods for activating “stimulator of interferon gene”—dependen2019
Compositions comprising cyclic purine dinucleotides having defined stereochemist2019
Vaccines for HSV-22019
Compositions and methods for inhibiting “stimulator of interferon gene”-dependen2019
Vaccines for HSV-22018
Methods and compositions using Listeria for enhancing immunogenicity by prime bo2018
Compositions and methods for cancer immunotherapy2017
Engineered Listeria and methods of use thereof2017